Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Australia And New Zealand On Track For Joint Drug Agency And A Single Point Of Entry For Pharma

This article was originally published in PharmAsia News

Executive Summary

Ongoing efforts to create a single regulator for medicines and therapeutic products in Australia and New Zealand got a boost last week when the two governments jointly announced plans to create a new agency within five yeas
Advertisement

Related Content

Australia and New Zealand Take First Steps To Joint Approval System For Drugs
Australia, New Zealand Consider Regulatory Reforms; PHARMAC To Add Sanofi Diabetes Agent Daonil: Australia, New Zealand Regulatory Roundup
Australia, New Zealand Consider Regulatory Reforms; PHARMAC To Add Sanofi Diabetes Agent Daonil: Australia, New Zealand Regulatory Roundup
Advertisement
UsernamePublicRestriction

Register

SC078343

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel